Loading interface...

Repepsa Tablet

Manufactured byAKUMENTIS HEALTHCARE LTD
Description

Repepsa Tablet is used in the treatment of stomach and intestinal ulcers. It is also used for the treatment of gastroesophageal reflux disease (GERD), a condition where acid from the stomach and bile irritates the food pipe, as well as other acidity-related disorders.

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now

Substitutes

List of substitutes for Repepsa Tablet

Kyrab 10 mg Tablet
Johnson & Johnson

Side effects

Major & minor side effects for Repepsa Tablet

  • Nausea and vomiting
  • Diarrhea
  • Abdominal pain
  • Headache
  • Nervousness
  • Excessive gas in stomach
  • Weakness

Uses of Repepsa Tablet

What is it prescribed for?

  • Gastric ulcer
  • Duodenal ulcer
  • Gastroesophageal Reflux Disease (GERD)
Read More
Concerns

Commonly asked questions

  • Onset of action
    The effect of this medicine can be observed within 1-3 hours of oral administration. The effect of this medicine can be observed rapidly after an intravenous administration.
  • Duration of effect
    The effect of this medicine lasts for an average duration of 24 hours.
  • Safe with alcohol?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is it habit forming?
    No habit forming tendency has been reported.
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking or receiving this medicine.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking or receiving this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to dexrabeprazole or any other inactive ingredients present along with it.

Severe liver impairment

This medicine is not recommended for use in patients suffering from severe liver impairment due to the increased risk of serious adverse effects.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking or receiving this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking or receiving this medicine.
General warnings

Clostridium difficile-associated Diarrhea

Use of this medicine has been associated with Clostridium difficile-associated diarrhea in some cases. Report any symptoms such as severe and persistent diarrhea, abdominal cramps, etc. to the doctor immediately. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Driving and operating machines

This medicine may cause dizziness or drowsiness in some patients. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Missed Dose

Oral forms: The missed dose of this medicine should be taken as soon as possible. It is advisable to skip the missed dose if it is already time for your next scheduled dose. Do not double the dose to make up for the missed one. Injection: Since this medicine is administered by a qualified health care professional in the clinical or hospital setting, the likelihood of a missed dose is very low.

Overdose

Oral forms: Seek emergency medical attention or contact your doctor in case of an overdose. Injection: Since this medicine is usually administered in the hospital or clinical setting by a qualified health care professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Itraconazole

Ketoconazole

Warfarin

Disease interactions

Liver impairment

This medicine should be used with caution in patients suffering from liver impairment due to the increased risk of severe adverse effects. This medicine is not recommended for use in patients suffering from severe liver impairment. Close monitoring of liver function tests, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.
Food interactions
Information not available.
Lab interactions
Information not available.
Oral forms: Take this medicine exactly as instructed by the doctor. Do not take in larger or smaller amounts than prescribed. Seek emergency medical treatment in case of any severe side effects. Ensure that the course of treatment is completed. Do not stop the use of this medicine without consulting your doctor. Injection: This medicine should be administered by a qualified health care professional in the clinical or hospital setting. Inform the doctor if you have a known history of allergy to this medicine. Report to the doctor all your current medicines as well as your medical conditions before receiving this medicine. Report any undesirable side effects to the doctor promptly.
Miscelleneous

To be taken before food

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine decreases the amount of acid produced in the stomach.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Proton pump inhibitors

Schedule

Schedule H

A postmarketing surveillance study of dexrabeprazole in the treatment of acid peptic disorders. - PubMed - NCBI [Internet]. Ncbi.nlm.nih.gov. 2018 [cited 11 September 2018]. Available from:

https://www.ncbi.nlm.nih.gov/pubmed/19585824

Randomized, double-blind, comparative study of dexrabeprazole 10 mg versus rabeprazole 20 mg in the treatment of gastroesophageal reflux disease. - PubMed - NCBI [Internet]. Ncbi.nlm.nih.gov. 2018 [cited 11 September 2018]. Available from:

https://www.ncbi.nlm.nih.gov/pubmed/17696229
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 27 May 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.